Pacira BioSciences, Inc.
PCRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001396814
In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.
Holders of 5% or more of PCRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pacira BioSciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.20%7.02M shares | – | Apr 28, 20251 filing | Apr 28, 2025 | SEC |
| Doma Perpetual Capital Management LLC | 13D/A | 7.30%2.94M shares | +0.47 ppfrom 6.83% | Aug 8, 20254 filings | Mar 12, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 6.38%2.59M shares | New | May 1, 20261 filing | May 1, 2026 | SEC |
| State Street Corp | 13G | 5.20%2.06M shares | New | Aug 7, 20261 filing | Aug 7, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.15%2.09M shares | New | May 1, 20261 filing | May 1, 2026 | SEC |
| Dimensional Fund Advisors LP | 13G | 5.10%2.06M shares | New | Apr 9, 20261 filing | Apr 9, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
31 Schedule 13D and 13G filings on Pacira BioSciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 202610:33 AM ET | State Street Corp | 13G | 5.20%2.06M shares | New | Jun 30, 2026 | SEC |
| May 1, 20268:51 AM ET | Vanguard Portfolio Management LLC | 13G | 6.38%2.59M shares | New | Mar 31, 2026 | SEC |
| May 1, 20268:39 AM ET | Vanguard Capital Management LLC | 13G | 5.15%2.09M shares | New | Mar 31, 2026 | SEC |
| Apr 9, 20261:42 PM ET | Dimensional Fund Advisors LP | 13G | 5.10%2.06M shares | New | Mar 31, 2026 | SEC |
| Mar 27, 202611:22 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Mar 12, 20267:57 PM ET | Doma Perpetual Capital Management LLCand 7 others | 13D/A | 7.30%2.94M shares | +0.47 ppfrom 6.83% | Mar 11, 2026 | SEC |
| Jan 2, 202612:18 PM ET | Doma Perpetual Capital Management LLCand 5 others | 13D/A | 6.83%2.94M shares | 0.00 ppfrom 6.83% | Dec 30, 2025 | SEC |
| Nov 13, 20252:29 PM ET | Renaissance Technologies LLCand 1 other | 13G/A | 4.98%2.14M shares | −0.36 ppfrom 5.34%Below 5% | Jul 1, 2025 | SEC |
| Nov 10, 20258:00 PM ET | Doma Perpetual Capital Management LLCand 5 others | 13D/A | 6.83%2.94M shares | +1.13 ppfrom 5.70% | Nov 6, 2025 | SEC |
| Aug 13, 20254:11 PM ET | Renaissance Technologies LLCand 1 other | 13G | 5.34%2.40M shares | – | Apr 8, 2025 | SEC |
| Aug 8, 20251:26 PM ET | Doma Perpetual Capital Management LLCand 5 others | 13D | 5.70%2.70M shares | New | Aug 1, 2025 | SEC |
| May 2, 202511:16 AM ET | Pacer Advisors, Inc.and 3 others | 13G/A | 1.28%601.7K shares | −5.65 ppfrom 6.93%Below 5% | Mar 31, 2025 | SEC |
| May 2, 202510:44 AM ET | Pacer Advisors, Inc.and 3 others | 13G | 6.93%3.26M shares | New | Dec 31, 2024 | SEC |
| Apr 28, 202512:17 PM ET | BlackRock, Inc. | 13G/A | 15.20%7.02M shares | – | Mar 31, 2025 | SEC |
| Apr 21, 20254:00 PM ET | Millennium Management LLCand 2 others | 13G/A | 0.70%345.6K shares | −4.40 ppfrom 5.10%Below 5% | Mar 31, 2025 | SEC |
| Jan 15, 20254:30 PM ET | Millennium Management LLCand 2 others | 13G | 5.10%2.34M shares | New | Jan 10, 2025 | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Macquarie Group Ltd | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 23, 20233:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Mar 2, 2022 | Baillie Gifford & Co | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Macquarie Group Ltd | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Jan 27, 20225:13 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 27, 2022 | Baillie Gifford & Co | 13GOld format | – | New | – | SEC |
| Jan 26, 20229:16 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Macquarie Group Ltd | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Renaissance Technologies LLC | 13GOld format | – | New | – | SEC |
| Feb 5, 20217:51 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Pacira BioSciences, Inc. shares.
No Form 144 notices for Pacira BioSciences, Inc. are on file.